Sytrinol® - Lowers Total Cholesterol
In the U.S., heart disease strikes and kills every 35 seconds. It's been the leading cause of death in the United States for the past 80 years and is the major cause of disability. It also results in substantial health-care expenditures; for example, coronary heart disease is projected to cost an estimated $150 billion in direct and indirect costs per annum. While there exists a myriad of advanced technological treatment tools to help deal with the problem, the single best course of action to be taken is one of “prevention.”
Sytrinol® is a patented and proprietary formula derived from natural citrus and palm fruit extracts. It combines polymethoxylated flavones (PMFs), delta, gamma, and alpha tocotrienols and other proprietary ingredient components.
Multiple clinical trials have demonstrated that Sytrinol acts synergistically to significantly improve total cholesterol, LDL cholesterol, and triglycerides up to 30%, 27%, and 34%, respectively, compared to placebo. Sytrinol has also been shown to increase HDL levels. Additionally, Sytrinol is a powerful anti-oxidant with numerous heart health benefits including the reduction of arterial plaque, improved glycemic control and reduced blood platelet aggregation.
All patents and trademarks associated with Sytrinol® are the exclusive property of Next Pharmaceuticals.
Sytrinol® includes Tocomin® tocotrienols as part of its formulation.